To test the hypothesis that AA transporter transcripts are present in the large intestine and similarly expressed along the intestinal tract, mRNA abundance of candidate AA transporter genes solute carrier (SLC) family 7, member 9 (SLC7A9), SLC7A1, SLC7A8, and SLC43A1 encoding for b 0,+ -type AA transporter (b 0,+ AT), cationic AA transporter-1 (CAT-1), L-type AA transporter-2 (LAT-2), and L-type AA transporter-3 (LAT-3), respectively, was determined in small and large intestinal segments of the horse. Mucosa was collected from the equine small (jejunum and ileum) and large intestine (cecum, left ventral colon, and left dorsal colon), flash frozen in liquid nitrogen, and stored at −80°C. Messenger RNA was isolated from tissue samples, followed by manufacture of cDNA. Relative quantitative reverse transcription-PCR was conducted using the 2 −ΔΔCT method, with glyceraldehyde-3-phosphate dehydrogenase serving as the housekeeping gene. Compared with the jejunum, cationic and neutral AA transporter SLC7A9 mRNA abundance was similar in the ileum, cecum, and large intestinal segments. Compared with the jejunum, cationic AA transporter SLC7A1 mRNA abundance was similar in the ileum and decreased in the cecum, left ventral colon, and left dorsal colon (P < 0.001). Neutral AA transporter SLC7A8 mRNA abundance decreased from the cranial to caudal end of the intestinal tract (P < 0.001). Neutral AA transporter SLC43A1 mRNA abundance was similar in the ileum and left dorsal colon and increased in the cecum (P < 0.01) and left ventral colon (P < 0.1) compared with the jejunum. Cationic and neutral AA transporter SLC7A9 mRNA abundance was similarly expressed in the large compared with small intestine, whereas cationic AA transporter SLC7A1 was of low abundance in the large intestine; neutral AA transporters SLC7A8 and SLC43A1 were differentially expressed with decreased abundance of SLC7A8 and increased abundance of SLC43A1 in the large intestine. Results indicate that the large intestine might contribute to both cationic and neutral AA uptake and absorption predominantly via transporters LAT-3 and b 0,+ AT.
INTRODUCTION
The gastrointestinal tract absorbs N of dietary and endogenous microbial origins (Fuller and Reeds, 1998) . Although there is no doubt as to the role of the small intestine in N absorption (Metges, 2000) , the contribution of the large intestine to N homeostasis of the host is largely unknown. As predominately hindgut fermenters, major sites of microbial digestion in the horse occur distal to the small intestine (i.e., in the cecum and large intestine; Reitnour et al., 1969; Reitnour and Salsbury, 1972; Gibbs et al., 1988) . Whereas only 11 to 30% of whole-tract apparent N digestion is attributed to the small intestine, as much as 40 to 70% appears to originate distal to the ileum (Reitnour et al., 1969; Gibbs et al., 1988) . However, the form of N absorbed from the cecum and large intestine of the horse is unknown. Knowledge of whether AA are absorbed from the large intestine would further our understanding of AA utilization in horses.
Amino acid transport across the small intestinal epithelial cells occurs via numerous transporter proteins varying in capacity and overlapping in specificity (Broer, 2008) . Characterizing molecular entities of AA transport in the equine small and large intestine would provide both an initial step in understanding the functional difference of AA absorption at a mechanistic level -type AA transporter (b 0,+ AT), cationic AA transporter-1 (CAT-1), L-type AA transporter-2 (LAT-2), and L-type AA transporter-3 (LAT-3), respectively, was determined in small and large intestinal segments of the horse.
MATERIALS AND METHODS
All methods were approved by the Institutional Animal Care and Use Committee at Michigan State University.
Animals and Collection of Tissue
Four mature horses (3 Standardbreds and 1 Thoroughbred; 2 geldings and 2 mares) fed a mixed alfalfa and timothy grass hay at 2% of BW and 1.4 kg of concentrate meal (10% CP, Purina Omolene, Land O'Lakes Purina Mills, Gray Summit, MO) were used. Horses were between the age of 3 and 10 yr and were killed for reasons other than history of gastrointestinal problems. After euthanasia, the horses were positioned in dorsal recumbency, and a 2.5-m incision was made along the ventral midline to expose the entire gastrointestinal tract. Approximately 20-cm-long sections were sampled from 2 segments of the small intestine (i.e., the distal jejunum and the ileum), the cecum, and 2 segments of the large intestine (i.e., the left ventral colon and left dorsal colon). Distal jejunal samples were obtained 12 m from the duodenal colic ligament. Ileal samples were collected within the segment of bowel located between the antimesenteric band and the linear artery. Cecal samples were obtained between the medial and ventral cecal bands, midway between the apex and the base. The left ventral colon was sampled between the sternal and pelvic flexures at the lateral band, and the left dorsal colon was sampled between the pelvic and diaphragmatic flexures in the antimesenteric area. After collection of each segment, the mucosal layer was gently pulled from the serosa, cut into small pieces (approximately 1 g), and immediately flash frozen in liquid N. Samples were stored at −80°C for later quantification of mRNA.
Isolation of RNA and Preparation of cDNA
Ribonucleic acid was extracted from the intestinal mucosa tissue using the Manual PerfectPure RNA Cell & Tissue Kit according to the manufacturer's instructions (5 PRIME, Gaithersburg, MD). Briefly, approximately 80 mg of tissue was homogenized in 800 µL of Lysis Solution using a Polytron (PT10/35, Kinematica Inc., Bohemia, NY). The homogenate was cleared of large particles by centrifugation at 400 × g for 1 min at 4°C in a preclear column. Lysates were then transferred to a purification column and centrifuged at 16,000 × g for 1 min at 4°C. Wash 1 Solution (400 µL) was added to each column, and lysates were again centrifuged at 16,000 × g for 1 min at 4°C. A DNase treatment was added, and the column was washed twice (200 µL) and centrifuged at 16,000 × g for 1 min at 4°C after each wash. Wash 2 Solution (200 µL) was added to each column, the column was centrifuged at 16,000 × g for 1 min at 4°C, and the wash was repeated. The resulting RNA was eluted from the purification column using 50 µL of Elution Solution. Isolated RNA was tested for purity by spectophotometry (NanoDrop 1000, Thermo Scientific, Wilmington, DE) and for quality (2100 Bioanalyzer, Agilent Technologies, Foster City, CA).
Complementary DNA was manufactured using SuperScript II Kit (Invitrogen, Carlsbad, CA) following the manufacturer's instructions. Briefly, 2 µg of purified RNA was added to 1 µL of dT 18 primer and double deionized H 2 O to provide a solution of 10 µL of total reaction volume. Samples were placed in a thermocycler for 5 min at 70°C, 5 min at 20°C, 60 min at 50°C, 5 min at 70°C, 20 min at 37°C, followed by holding at 4°C. Master dNTP mix (10 µL) was added after the denaturation step, and 0.5 µL of RNase H (Invitrogen) was added after cDNA manufacturing. Once complete, 0.2 µL of 0.5M EDTA was added to each sample, and the contents were transferred to a new tube. Ethanol (125 µL) was added, and the sample was stored at −20°C overnight to precipitate the cDNA pellet. After incubation, samples were centrifuged at 16,000 × g for 20 min at 4°C to obtain a cDNA pellet, which was washed in 1 mL of 75% ethanol, dried, and quantified by spectrophotometry (NanoDrop 1000, Thermo Scientific). Complementary DNA was then diluted to a working stock of 10 ng/µL and stored at −20°C.
Measurement of SLC7A9, SLC7A1, SLC7A8, and SLC43A1 Relative mRNA Abundance by Quantitative Reverse Transcription-PCR
Primers for quantifying mRNA abundance of the candidate AA transporter genes SLC7A9, SLC7A1, SLC7A8, and SLC43A1 were designed based on the equine gene sequences deposited in the National Center for Biotechnology Information (2009) Entrez Gene (Table 1 ) using software (Primer Express, v. 3.0, Applied Biosystems, Foster City, CA). Water and primers, optimized by matrix analysis, as described by Mikeska and Dobrovic (2009) , were added to a 96-well PCR plate, followed by the working cDNA stock and SYBR green (Applied Biosystems). Amplification of cDNA and fluorescence detection were carried out using an automated fluorometer (ABI 7000 using ABI Prism 7000 SDS software, Applied Biosystems) for quantitative PCR. Conditions for amplification and quantification included initial denaturing stages (50°C for 2 min and 95°C for 10 min) followed by 40 cycles of 2 amplification stages (95°C for 15 s and 60°C for 1 min) for primer annealing and elongation. A dissociation stage (95°C for 15 s, 60°C for 1 min, and 95°C for 15 s) was added at the end of amplification to ensure a single amplicon was produced and to validate the primer pairs. Observed melting temperatures, a sensitive measure of length and sequence for DNA products, differed by less than 5°C from the predicted values (Table 1) . A nontemplate control (RNase-free water) was used for every primer pair during each quantitative PCR run. Relative abundance of SLC7A9, SLC7A1, SLC7A8, and SLC43A1 mRNA was quantified in duplicate using the 2 −ΔΔCT method (Livak and Schmittgen, 2001 ) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the normalizing gene. Fold change in AA transporter mRNA abundance in each intestinal segment was determined using the jejunum as a positive control, based on evidence that AA and peptide transporter expression is increased in the jejunum and ileum compared with the duodenum in other animal species (Chen et al., 1999; Segawa et al., 1999; Hatanaka et al., 2002; Fraga et al., 2005; Gilbert et al., 2007; Li et al., 2008; Liao et al., 2008; Wang et al., 2009 ).
Statistical Analysis
Data were analyzed using the PROC MIXED procedure (SAS Inst. Inc., Cary, NC). The model included the fixed effect of intestinal tract section and the random effect of horse. Student's t-test was used to compare the mean cycles to threshold (C T ) of each segment to the mean C T of the jejunum for each transporter. Differences in C T were log-transformed to represent fold change in mRNA abundance according to the 2 −ΔΔCT method (Livak and Schmittgen, 2001) . Results are reported as the fold change in each segment relative to the jejunum. Data are expressed as mean fold change ± SEM. Significant and marginally significant differences in expression are reported at P < 0.05 and P < 0.10, respectively.
RESULTS
Messenger RNA abundance of GAPDH was not different between segments (P = 0.98); C T in the jejunum, ileum, cecum, left ventral colon, and left dorsal colon were 23.3, 23.1, 22.7, 23.1, and 22.6, respectively, demonstrating the suitability of GAPDH as a normalizing gene in this study. Compared with the jejunum, mRNA abundance of transporter gene SLC7A9 tended to decrease in the ileum (P = 0.07) and did not differ in the cecum (P = 0.54), left ventral colon (P = 0.26), and left dorsal colon (P = 0.67; Figure 1A ). Transporter genes SLC7A1 ( Figure 1B ) and SLC7A8 ( Figure 1C ) mRNA abundance in the ileum did not differ (P = 0.46 and 0.81, respectively) compared with the jejunum and decreased (P < 0.001) in the cecum, left ventral colon, and left dorsal colon. For transporter gene SLC43A1 ( Figure 1D ), compared with the jejunum, mRNA abundance did not differ in the ileum (P = 0.57), increased in the cecum (P < 0.01), tended to increase in the left ventral colon (P = 0.07), and did not differ in the left dorsal colon (P = 0.77).
DISCUSSION
Equids are equipped with both significant hydrolytic and fermentative digestive capability in the proximal and distal gastrointestinal tract, respectively, making them an attractive model for the study of differential mechanisms of nutrient absorption. We hypothesized that the equine large intestinal mucosa expresses the transcript for AA transporters known in vertebrates to transfer indispensable AA across cell membranes. This hypothesis is based on the notion that horses meet both energy and protein demand through hindgut fermentation and appear to assimilate a large proportion of dietary N from regions distal to the small intestine (Reitnour et al., 1969; Reitnour and Salsbury, 1972; Gibbs et al., 1988) . Although the equine large intestine appears to play a significant role in N absorption of both exogenous and microbial origin (Reitnour et al., 1969; Reitnour and Salsbury, 1972; Gibbs et al., 1988) , very little is known regarding the form of N absorbed from the cecum and large intestine. Slade et al. (1971) demonstrated postileal uptake of 15 N-labeled lysine and other indispensable AA in ponies after placing uniformly 15 N-labeled bacteria in the cecum. Even in animals primarily relying on hydrolytic digestion, fermentation of dietary fiber leads to the synthesis of microbial proteins that could contribute to the N homeostasis in the host (Metges, 2000) . For instance, in human subjects who have undergone ileostomy, digestibility of fiber components and AA is less (Rowan et al., 1994) and circulating plasma AA concentrations are less than in humans with intact tract digestive systems (Metges et al., 1999) .
This study begins to address differential mechanisms of AA absorption between the orad and aborad regions of the gastrointestinal tract of the horse by profiling the mRNA abundance of target genes collectively responsible in part for transport of cationic and large neutral AA. Our candidate genes included SLC7A9, SLC7A1, SLC7A8, and SLC43A1, encoding for AA transporters b 0,+ AT, CAT-1, LAT-2, and LAT-3, respectively. For the remainder of the manuscript, the common AA transporter protein names will be used in place of their gene names. All 4 AA transporters belong to Na + -independent systems of AA transporters. Transporter CAT-1 belongs to the y + transport system, and transporter b 0,+ AT belongs to the b 0,+ system of AA transport. Both systems share functional properties in that they display high affinity for cationic AA and low and medium, respectively, transport capacity (Broer, 2008) . Transporters LAT subtype 2 (LAT-2) and LAT subtype 3 (LAT-3) belong to the L system of AA transport and have medium and low affinity, respectively, for neutral AA and high transport capacity (Broer, 2008) .
In this study, abundance of b 0,+ AT transcript was uniform across all segments of the equine intestinal tract. Others have reported b 0,+ AT mRNA abundance throughout the duodenum, jejunum, and ileum of broilers (Gilbert et al., 2007 , pigs (Wang et al., 2009) contrast to our study, Dave et al. (2004) and Feng et al. (2008) reported a decrease in b 0,+ AT mRNA abundance in mice and pig colon, respectively, compared with small intestine. Significant large intestinal b 0,+ AT mRNA abundance has not been reported elsewhere.
Transporter CAT-1 mRNA has been reported throughout the small intestine of both broilers (Gilbert et al., 2007; Li et al., 2008) and steers (Liao et al., 2008 (Liao et al., , 2009 ). In our study, CAT-1 was predominately expressed in the jejunum and ileum, with little to no detectable mRNA in the cecum and large intestine, respectively. Gilbert et al. (2007) reported similar abundance of CAT-1 between the small intestinal segments of broilers, whereas the greatest CAT-1 mRNA expression was found in either the jejunum or duodenum of growing steers (Liao et al., 2008 (Liao et al., , 2009 ). To our knowledge, this study is the first to characterize and report on the pre-and postileal mRNA expression profile of CAT-1 transporter.
Similar to b 0,+ AT, LAT-2 mRNA abundance was detected in all segments. However, the abundance decreased from the proximal to distal segments, reaching an 18-fold reduction in the left dorsal colon. In mice, LAT-2 mRNA abundance was only found in the jejunum and ileum, with no transcript detected in the colon (Segawa et al., 1999) . In rats, however, LAT-2 mRNA abundance was shown in the jejunum, ileum, and the colon, with no differential expression found between these segments (Fraga et al., 2005) . In regard to the AA transporter LAT-3, there is limited information on its molecular and functional characteristics. So far, one study has reported LAT-3 mRNA abundance in the duodenum of human, mice, and rat (Kim et al., 2007) . In that study, mRNA was isolated only from the duodenum; consequently, differential abundance in other segments was unknown.
We found both b 0,+ AT and LAT-3 to have similar or greater, respectively, mRNA abundance in all segments of the equine intestinal tract compared with the jejunum. Amino acid transporter b 0,+ AT has a high affinity for cystine and cationic AA (Dave et al., 2004; Wang et al., 2009 ). The distribution of b 0,+ AT in the cecum and colon appears to be unique to the horse; others have not identified significant b 0,+ AT expression in the large intestine of mice (Dave et al., 2004) or pigs (Feng et al., 2008) . Expression of b 0,+ AT is localized to the apical membrane of the small intestine in mice (Dave et al., 2004 ) and is considered the major cationic AA transporter in the intestine of mice (Wang et al., 2009 ). Feng et al. (2008 suggested the decreased expression in pig colon was due to low postcecal AA availability; therefore, our findings might be relevant to the AA nutrition of horses and other mammals relying on microbial protein predominantly produced from dietary fiber fermentation occurring distal to the small intestine. In contrast to b 0,+ AT, AA transporter LAT-3 is a high-capacity and low-affinity transporter for neutral AA (Broer, 2008) , with the greatest mRNA abundance in the large intestine. Fraga et al. (2005) found greater LAT-1 mRNA abundance in the rat colon compared with the jejunum and suggested that this might result from long-term adaptive response to decreased AA availability in the large intestine. Accordingly, increased presence of AA transporter LAT-3 transcript might be necessary to maximize absorption of neutral AA in the equine large intestine.
Of the 4 candidate genes characterized in this study and known to transport cationic and neutral AA across epithelial cells of other animal species, 3 were expressed in the equine large intestine. These transporters might facilitate the absorption of microbial and dietary-derived AA across the epithelium of the large intestine. Only CAT-1 was uniquely localized to segments of the small intestine. Together, the presence of both highaffinity (b 0,+ AT) and high-capacity (LAT-2 and LAT-3) AA transporters indicates that the large intestine might contribute to both cationic and neutral AA uptake and absorption. Whether the observed differential mRNA abundances between segments and among the AA transporters studied translate into transporter protein levels or functional and phenotypic expression remains to be determined. Nonetheless, this study is novel and the first to report on the profile of AA transporter transcript abundances along the gastrointestinal tract of the horse. These results, along with future studies kinetically defining AA uptake, will be useful in estimating the contribution of the large intestine to N homeostasis of the horse.
